EUVIMEDEUVIMED entdecken
Crossref

Wogonin attenuates inflammation and oxidative stress in acute lung injury via regulating PPARα, AKT, and NRF2

Hui Yang, Yunran Hu, Long Cheng, Yuan Xiong, Yuan Xu, Changxing Gao, Ming Qian, Lin Zhou

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

DOI: 10.1007/s00210-025-03889-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Hui Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Nanjing Drum Tower Hospital, Nanjing Drum Tower Hospital Clinical College, Nanjing University of Chinese Medicine, Nanjing, 210023, China. Hauptthemen laut MEDLINE: Acute Lung Injury, Flavanones, NF-E2-Related Factor 2, Oxidative Stress. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The study aims to clarify the therapeutic effect and underlying mechanisms of wogonin (WOG) against acute lung injury (ALI). Lipopolysaccharide-induced in vivo ALI mice model and in vitro RAW264.7 cell model were established. Lung histopathologic changes were assessed by H&E staining. Inflammatory cell infiltration in lung tissues and bronchoalveolar lavage fluid (BALF) was determined using H&E staining and flow cytometry. Inflammatory cytokines, reactive oxygen species (ROS), and antioxidant mediators were quantified. Potential targets of WOG were identified by bioinformatics and network pharmacology and further verified by Western blotting. WOG treatment (10 mg/kg, 20 mg/kg, 40 mg/kg) alleviated lung injury of ALI mice by ameliorating infiltration of inflammatory cells in lung tissues and BALF, inhibiting inflammatory cytokines, elevating antioxidant mediator levels, and attenuating lung edema. In RAW264.7 cells, WOG treatment (10 μM, 20 μM, 40 μM) also suppressed inflammatory response and oxidative stress. Peroxisome proliferator-activated receptor α (PPARα), protein kinase B (AKT), and nuclear factor erythroid 2-related factor 2 (NRF2) were predicted to be the targets of WOG against ALI by integrating the network pharmacology database and the GSE1871 dataset. Interestingly, WOG markedly promoted the expression and activation of PPARα and NRF2, while it inhibited the expression and phosphorylation of AKT both in vivo and in vitro. We provided a comprehensive insight into investigating the therapeutic effect of WOG against ALI via ameliorating inflammation and oxidative stress through regulating PPARα, AKT, and NRF2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Lung InjuryFlavanonesNF-E2-Related Factor 2Oxidative StressProto-Oncogene Proteins c-aktPPAR alphaAnti-Inflammatory AgentsAnimalsRAW 264.7 CellsMiceMaleLipopolysaccharidesInflammationLungMice, Inbred C57BLAntioxidantsSignal TransductionBronchoalveolar Lavage FluidDisease Models, AnimalCytokines

Stichwörter der Autor:innen

Acute lung injuryInflammationOxidative stressWogonin

Substanzen

FlavanonesNF-E2-Related Factor 2Proto-Oncogene Proteins c-aktNfe2l2 protein, mousewogoninPPAR alphaAnti-Inflammatory AgentsLipopolysaccharidesAntioxidantsCytokines

Autor:innen und Institutionen

  • Nanjing Drum Tower Hospital, Nanjing Drum Tower Hospital Clinical College, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
  • Department of Pharmacy, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210008, China.
  • Nanjing Drum Tower Hospital, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 210009, China.
  • Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, 210042, China.
  • Department of Pharmacy, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210008, China. 19850859692@163.com.
  • Nanjing Drum Tower Hospital, Nanjing Drum Tower Hospital Clinical College, Nanjing University of Chinese Medicine, Nanjing, 210023, China. linzhou@njglyy.com.

Förderung

  • National Natural Science Foundation of China
  • National Natural Science Foundation of Jiangsu Province

Zitieren

APA

Yang, H., Hu, Y., Cheng, L., Xiong, Y., Xu, Y., Gao, C., Qian, M., & Zhou, L. (2025). Wogonin attenuates inflammation and oxidative stress in acute lung injury via regulating PPARα, AKT, and NRF2. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-03889-3

Vancouver

Yang H, Hu Y, Cheng L, Xiong Y, Xu Y, Gao C, et al. Wogonin attenuates inflammation and oxidative stress in acute lung injury via regulating PPARα, AKT, and NRF2. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-025-03889-3

BibTeX
@article{Yang2025,
  author = {Yang, Hui and Hu, Yunran and Cheng, Long and Xiong, Yuan and Xu, Yuan and Gao, Changxing and Qian, Ming and Zhou, Lin},
  title = {Wogonin attenuates inflammation and oxidative stress in acute lung injury via regulating PPARα, AKT, and NRF2},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  doi = {10.1007/s00210-025-03889-3}
}
Kostenlos starten →